One month of dual antiplatelet therapy (DAPT) followed by 11 months of clopidogrel monotherapy failed to prove noninferiority to 12 unbroken months of DAPT for net clinical benefit in a multicenter ...
(UPDATED) A 1-month dual antiplatelet strategy tested in the STOPDAPT-2 ACS trial has failed to match the results for safety and efficacy seen in the original, all-comers STOPDAPT-2 study, researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback